Ulcosilvanil

anti-ulcer agent used in differentiation of benign & malignant gastric niches; may be related to acetazolamide; no other chemical information available 7/22/81; contains mainly acetazolamide & small amounts of sodium- & potassium bicarbonate 8/87

Networked: 10 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Related Diseases

1.	Peptic Ulcer (Peptic Ulcers) 04/01/1987 - "Treatment of gastroduodenal ulcer by "Ulcosilvanil"." 01/01/1987 - "[Treatment of gastroduodenal ulcer with ulcosilvanil]." 11/01/1985 - "[Comparative study of treatment with the classical method and with Ulcosilvanil in gastroduodenal ulcer]." 01/01/1984 - "[Treatment of peptic ulcer with ulcosilvanil]." 07/01/1983 - "[Endoscopic follow-up of recurrences of gastroduodenal ulcer after treatment with Ulcosilvanil (4-year study)]."
2.	Ulcer 07/01/1980 - "[Prevention of stress- induced and indomethacin-induced ulcer by administration of Ulcosilvanil in rats]." 04/01/1987 - "The high percentage and the quick ulcer healing by "Ulcosilvanil", as compared with antacid and anticholinergic therapy or with H2-receptor blocking agents, prove the outstanding therapeutical value of the former."
3.	Stomach Ulcer (Gastric Ulcer) 04/01/1987 - ""Ulcosilvanil" (Romanian registered mark), administered in duodenal and gastric ulcer patients, leads to a constant and long-lasting inhibition of gastric acid secretion, consequently to disappearance of subjective symptoms as well as to radiologically and endoscopically proved healing of the crater. " 07/01/1980 - "[Treatment of gastric ulcers with Ulcosilvanil. "
4.	Duodenal Ulcer (Curling's Ulcer) 07/01/1980 - "[Endoscopic follow-up study of the healing of duodenal ulcer after treatment with Ulcosilvanil]." 01/01/1986 - "Knowing the in vivo inhibitory effect of the beta-adrenoreceptor antagonists on gastric mucosa carbonic anhydrase and the high clinical efficacy of "Ulcosilvanil" in the healing of gastric and duodenal ulcers, the authors combined propranolol with smaller doses of "Ulcosilvanil" in 925 active duodenal ulcer patients, divided into four groups. " 01/01/1986 - ""Ulcosilvanil"--an inhibitor of carbonic anhydrase--associated with adrenergic beta-blockers in the treatment of duodenal ulcers."

Related Drugs and Biologics

1.	Cholinergic Antagonists (Anticholinergics)
2.	Propranolol (Inderal)
3.	Indomethacin (Indometacin)
4.	Histamine H2 Antagonists
5.	Carbonic Anhydrases (Carbonic Anhydrase)
6.	Antacids
7.	Adrenergic beta-Antagonists (beta-Adrenergic Blocking Agents)

Related Therapies and Procedures

1.	Aftercare (After-Treatment)
2.	Therapeutics